Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 63.00
+3.45 (5.79%)
Jun 18, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 32.37 billion as of June 18, 2026. Its market cap has increased by 39.46% in one year.
Market Cap
32.37B
Enterprise Value
35.43B
Revenue
7.42B
Ranking
n/a
PE Ratio
35.44
Stock Price
63.00
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 32.37B, an increase of 21.40%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 32.37B | 4.38% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 82.30B |
| RemeGen | 60.91B |
| 3SBio | 42.76B |
| Biocytogen Pharmaceuticals (Beijing) | 39.27B |
| Shanghai Junshi Biosciences | 31.17B |
| Genscript Biotech | 25.82B |
| InnoCare Pharma | 22.83B |
| Keymed Biosciences | 17.15B |